Harpoon Therapeutics

Developer of T-cell antibodies against hematologic and solid tumor targets

placeCambridge, Massachusetts, United States calendar_todayFounded 2015 groups93 employees language harpoontx.com

Registered entities

Investor mix

19 investors on record; lead investors include Orbimed, New Leaf Venture Partners, Arix Bioscience; 3 have since exited.

Investor typeCountShare
Venture capital842%
Private equity526%
Bank & private debt211%
Other / undisclosed421%
Coming soon